Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025)

Evaxion A (EVAX) posted Other Accumulated Expenses of $1.2 million for Q2 2025, up 24.6% on a QoQ basis from $927000.0 in Q4 2024, and up 56.5% year-over-year from $738000.0 in Q2 2024.

Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Evaxion A's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $1.2 million for Q2 2025.

  • Quarterly Other Accumulated Expenses rose 56.5% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.2 million (up 56.5% YoY) and the FY2024 annual result came in at $927000.0, down 7.85% from the prior year.
  • Other Accumulated Expenses was $1.2 million for Q2 2025 at Evaxion A, up from $927000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.1 million in Q2 2021 and bottomed at $665000.0 in Q4 2022.
  • A 5-year average of $1.4 million and a median of $1.0 million in 2021 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses sank 70.86% — and 2023, when it surged 60.02%.
  • Evaxion A's Other Accumulated Expenses stood at $1.0 million in 2021, then tumbled by 35.75% to $665000.0 in 2022, then surged by 51.28% to $1.0 million in 2023, then retreated by 7.85% to $927000.0 in 2024, then rose by 24.6% to $1.2 million in 2025.
  • Business Quant data shows EVAX's Other Accumulated Expenses at $1.2 million in Q2 2025, $927000.0 in Q4 2024, and $738000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn -
2 Nanobiotix 1,911.11 Bn 1,911.05 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 467.81 Bn 463.02 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.92 Bn 115.68 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.28 Bn 61.53 Bn 3.31 Bn
7 Belite Bio 62.88 Bn 62.88 Bn -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Evaxion A 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.16 Mn
Dec 31, 2024 927,000.00
Jun 30, 2024 738,000.00
Dec 31, 2023 1.01 Mn
Jun 30, 2023 1.49 Mn
Dec 31, 2022 665,000.00
Jun 30, 2022 933,000.00
Mar 31, 2022 744,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 2.91 Mn
Jun 30, 2021 3.11 Mn
Mar 31, 2021 2.55 Mn
Dec 31, 2020 2.26 Mn